S Squared Technology LLC grew its holdings in DocGo Inc. (NASDAQ:DCGO – Free Report) by 52.2% during the second quarter, HoldingsChannel reports. The firm owned 2,878,286 shares of the company’s stock after acquiring an additional 987,310 shares during the period. DocGo comprises about 1.9% of S Squared Technology LLC’s investment portfolio, making the stock its 20th biggest holding. S Squared Technology LLC’s holdings in DocGo were worth $4,519,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also made changes to their positions in DCGO. Bank of New York Mellon Corp increased its holdings in shares of DocGo by 8.1% in the first quarter. Bank of New York Mellon Corp now owns 365,468 shares of the company’s stock valued at $965,000 after purchasing an additional 27,309 shares during the last quarter. Diversify Wealth Management LLC purchased a new stake in DocGo in the 1st quarter valued at $223,000. Isthmus Partners LLC increased its stake in shares of DocGo by 2.3% in the 1st quarter. Isthmus Partners LLC now owns 638,400 shares of the company’s stock worth $1,685,000 after acquiring an additional 14,472 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of DocGo by 546.1% during the 1st quarter. Victory Capital Management Inc. now owns 372,487 shares of the company’s stock worth $983,000 after acquiring an additional 314,838 shares during the period. Finally, Jefferies Financial Group Inc. raised its holdings in shares of DocGo by 6,874.1% during the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company’s stock worth $5,358,000 after acquiring an additional 2,000,356 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
DocGo Trading Up 3.7%
Shares of NASDAQ:DCGO opened at $1.11 on Monday. The company has a market capitalization of $108.57 million, a price-to-earnings ratio of -5.84 and a beta of 0.93. DocGo Inc. has a 12-month low of $1.01 and a 12-month high of $5.68. The business has a 50-day moving average price of $1.33 and a 200 day moving average price of $1.50.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the stock. Canaccord Genuity Group upped their price objective on shares of DocGo from $1.45 to $1.60 and gave the company a “hold” rating in a report on Thursday, August 21st. Zacks Research upgraded shares of DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of DocGo in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, DocGo currently has a consensus rating of “Hold” and a consensus target price of $3.24.
Read Our Latest Research Report on DCGO
DocGo Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
- Five stocks we like better than DocGo
- How to Calculate Inflation Rate
- 2 Reasons to Buy Into Lam’s 185% Rally, 1 Reason to Run Away
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Alternative Energy ETFs That Are Crushing the Market This Year
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
